⌘K

Home/Filings/4/0000899243-23-006004

4//SEC Filing

AHMED NADIM 4

Accession 0000899243-23-006004

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:06 PM ET

Size

12.3 KB

Accession

0000899243-23-006004

Insider Transaction Report

Form 4

Period: 2023-02-22

Cullinan Oncology, Inc.CGEM

DirectorPresident and CEO

Transactions

Award
Common Stock
2023-02-22+109,000→ 118,710 total
Award
Stock Option (Right to Buy)
2023-02-22+211,000→ 211,000 total
Exercise: $11.03Exp: 2033-02-21→ Common Stock (211,000 underlying)

Footnotes (2)

[F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
[F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Documents

2 files

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 5:06 PM ET
Size: 12.3 KB

View on SEC.gov